Portfolio

Investments

View all

Ardelyx, Inc.

Focused on the discovery and development of novel therapeutics acting exclusively in the gastrointestinal tract and devoid of systemic exposure

Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current

Associated Team Members:
Ali Behbahani, MD

Board Members:
David Mott

Back to Previous